CD1b Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


CD1b Antibody
Description :
This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.Specifications :
ELISA (order BSA/sodium azide-free format for coating), Flow cytometry: 0.5-1ug/10^6 cells, Immunofluorescence: 0.5-1 µg/mLHost :
MouseReactivity :
HumanImmunogen :
Human peripheral lymphocytes were used as the immunogen for this CD1b antibody.Clonality :
MonoclonalIsotype :
IgG1 kClone :
RIV12Applications :
ELISA, FACS, IFPurity :
Protein G affinity chromatographyFormat :
PurifiedBuffer :
1X PBS, pH 7.4Reconstitution :
Store the CD1b antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).Limitations :
This CD1b antibody is available for research use only.Storage Conditions :
Store the CD1b antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide) .Formulation :
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05% sodium azideApplications Notes :
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CD1b antibody to be titered up or down for optimal performance.CAS Number :
9007-83-4Location :
Cell surface, cytoplasmicImage Legend :
FACS staining of human PBMCs using CD1b antibody (RIV12) .

